ReP USP - Resultado da busca

Artigo de periodico
The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 (2023)
Carvalho, Jonatan C. S. de; Silva Neto, Pedro V. da; Toro, Diana Mota; Fuzo, Carlos Alessandro; Nardini, Viviani; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Fraga-Silva, Thais Fernanda de Campos; Oliveira, Camilla N. S.; Degiovani, Augusto M.; Ostini, Fátima Magro; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Rocha, José Joaquim Ribeiro da; Féres, Omar; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Santos, Isabel Kinney Ferreira de Miranda; Fernandes, Ana Paula Morais; Maruyama, Sandra Regina Costa; Russo, Elisa Maria de Sousa; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Dias-Baruffi, Marcelo; Faccioli, Lucia Helena; Sorgi, Carlos Arterio
Source: Viruses. Unidades: FMRP, EERP, FCFRP, FFCLRP, FM
Subjects: COVID-19, HORMÔNIOS GLICOCORTICOIDES, FATOR DE ATIVAÇÃO DE PLAQUETAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Jonatan C. S. de et al. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, v. 15, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020573. Acesso em: 07 nov. 2024.
APA
Carvalho, J. C. S. de, Silva Neto, P. V. da, Toro, D. M., Fuzo, C. A., Nardini, V., Pimentel, V. E., et al. (2023). The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, 15. doi:10.3390/v15020573
NLM
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v15020573
Vancouver
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v15020573
Artigo de periodico
Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men (2023)
Duarte-Silva, Murillo ; Oliveira, Camilla Narjara Simão; Fuzo, Carlos Alessandro ; Silva Neto, Pedro Vieira da; Toro, Diana Mota; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Fraga-Silva, Thais Fernanda de Campos ; Carvalho, Jonatan Constança Silva de; Santos Neto, Firmino Martins dos; Martins Júnior, Ronaldo Bragança; Arruda Neto, Eurico de; Vilar, Fernando Crivelenti; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim ; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da; Féres, Omar; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina Costa; Russo, Elisa Maria de Sousa ; Bonato, Vânia Luiza Deperon ; Santos, Isabel Kinney Ferreira de Miranda ; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Cardoso, Cristina Ribeiro de Barros
Source: Brain, Behavior, and Immunity. Unidades: FMRP, FCFRP, EERP, FFCLRP
Subjects: TESTOSTERONA, DIIDROTESTOSTERONA, RECEPTORES ADRENÉRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE-SILVA, Murillo et al. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, v. 114, p. 275-286, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbi.2023.08.026. Acesso em: 07 nov. 2024.
APA
Duarte-Silva, M., Oliveira, C. N. S., Fuzo, C. A., Silva Neto, P. V. da, Toro, D. M., Pimentel, V. E., et al. (2023). Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, 114, 275-286. doi:10.1016/j.bbi.2023.08.026
NLM
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Vancouver
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Artigo de periodico
The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule (2022)
Cordeiro, Jéssica Fernanda Corrêa ; Fernandes, Talita Morais ; Toro, Diana Mota; Silva-Neto, Pedro V. da; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez ; Carvalho, Jonatan Constança Silva de; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla Narjara Simão; Argolo, Jamille Guedes Malta; Degiovani, Augusto Marcussi; Ostini, Fátima Magro; Puggina, Enrico Fuini ; Silva, João Santana da ; Santos, Isabel Kinney Ferreira de Miranda ; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Donadi, Eduardo Antônio ; Sorgi, Carlos Arterio ; Fernandes, Ana Paula Morais
Source: International Journal of Molecular Sciences. Unidades: FMRP, FCFRP, FFCLRP, EERP, RUSP, EE/EERP
Subjects: COVID-19, CITOCINAS, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Jéssica Fernanda Corrêa et al. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule. International Journal of Molecular Sciences, v. 23, n. 17, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23179736. Acesso em: 07 nov. 2024.
APA
Cordeiro, J. F. C., Fernandes, T. M., Toro, D. M., Silva-Neto, P. V. da, Pimentel, V. E., Pérez, M. M., et al. (2022). The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule. International Journal of Molecular Sciences, 23( 17), 1-16. doi:10.3390/ijms23179736
NLM
Cordeiro JFC, Fernandes TM, Toro DM, Silva-Neto PV da, Pimentel VE, Pérez MM, Carvalho JCS de, Fraga-Silva TF de C, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puggina EF, Silva JS da, Santos IKF de M, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 17): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/ijms23179736
Vancouver
Cordeiro JFC, Fernandes TM, Toro DM, Silva-Neto PV da, Pimentel VE, Pérez MM, Carvalho JCS de, Fraga-Silva TF de C, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puggina EF, Silva JS da, Santos IKF de M, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 17): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/ijms23179736
Artigo de periodico
Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress (2022)
Silva-Neto, Pedro V. da; Valle, Valéria Beatriz do; Fuzo, Carlos Alessandro; Fernandes, Talita Morais; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Basile, Patrícia Adriana; Carvalho, Jonatan Constança Silva de; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Oliveira, Camilla Narjara Simão; Rodrigues, Lilian Cataldi ; Bastos, Victor Alexandre Félix; Tella, Sandra de Oliveira Conde; Martins, Ronaldo Bragança; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Arruda, Eurico; Maruyama, Sandra R.; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Tanus-Santos, José Eduardo ; Donadi, Eduardo Antônio; Faccioli, Lucia Helena ; Dias-Baruffi, Marcelo; Fernandes, Ana Paula Morais ; Gerlach, Raquel Fernanda; Sorgi, Carlos Arterio
Source: Biomolecules. Unidades: FORP, FCFRP, FMRP, EERP, FFCLRP
Subjects: METALOPROTEINASES, PEROXIDASE, LIPÍDEOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-NETO, Pedro V. da et al. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, v. 12, n. 5, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12050604. Acesso em: 07 nov. 2024.
APA
Silva-Neto, P. V. da, Valle, V. B. do, Fuzo, C. A., Fernandes, T. M., Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, 12( 5), 1-20. doi:10.3390/biom12050604
NLM
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/biom12050604
Vancouver
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/biom12050604
Artigo de periodico
Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity (2022)
Pérez, Malena Martínez; Pimentel, Vinícius Eduardo; Fuzo, Carlos Alessandro; Silva Neto, Pedro Vieira da; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Gardinassi, Luiz Gustavo Araujo ; Oliveira, Camilla Narjara Simão; Souza, Camila O. S.; Torre Neto, Nicola T.; Carvalho, Jonatan Constança Silva de; Leo, Thais Canassa de ; Takahashi, Viviani Nardini ; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Constant, Leticia F.; Ostini, Fátima M.; Degiovani, Augusto Marcussi; Amorim, Alessandro P.; Viana, Angelina Lettiere ; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina; Russo, Elisa Maria de Sousa ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo; Faccioli, Lucia Helena ; Carmona-Garcia, Ingryd; Milanezi, Cristiane Maria; Zaparoli, Kamila; Garbato, Caroline Tempesta; Argolo, Jamille Guedes Malta
Source: The Journal of Immunology. Unidades: FCFRP, FMRP, EERP, FFCLRP, EE/EERP
Subjects: ACETILCOLINA, ÁCIDOS ARAQUIDÔNICOS, COVID-19, ÁCIDOS GRAXOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PÉREZ, Malena Martínez et al. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity. The Journal of Immunology, v. 209, n. 2, p. 250-261, 2022Tradução . . Disponível em: https://doi.org/10.4049/jimmunol.2200079. Acesso em: 07 nov. 2024.
APA
Pérez, M. M., Pimentel, V. E., Fuzo, C. A., Silva Neto, P. V. da, Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity. The Journal of Immunology, 209( 2), 250-261. doi:10.4049/jimmunol.2200079
NLM
Pérez MM, Pimentel VE, Fuzo CA, Silva Neto PV da, Toro DM, Silva TF de CF da, Gardinassi LGA, Oliveira CNS, Souza COS, Torre Neto NT, Carvalho JCS de, Leo TC de, Takahashi VN, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Constant LF, Ostini FM, Degiovani AM, Amorim AP, Viana AL, Fernandes APM, Maruyama SR, Russo EM de S, Santos IKF de M, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH, Carmona-Garcia I, Milanezi CM, Zaparoli K, Garbato CT, Argolo JGM. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity [Internet]. The Journal of Immunology. 2022 ; 209( 2): 250-261.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4049/jimmunol.2200079
Vancouver
Pérez MM, Pimentel VE, Fuzo CA, Silva Neto PV da, Toro DM, Silva TF de CF da, Gardinassi LGA, Oliveira CNS, Souza COS, Torre Neto NT, Carvalho JCS de, Leo TC de, Takahashi VN, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Constant LF, Ostini FM, Degiovani AM, Amorim AP, Viana AL, Fernandes APM, Maruyama SR, Russo EM de S, Santos IKF de M, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH, Carmona-Garcia I, Milanezi CM, Zaparoli K, Garbato CT, Argolo JGM. Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity [Internet]. The Journal of Immunology. 2022 ; 209( 2): 250-261.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4049/jimmunol.2200079
Artigo de periodico
sTREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity (2021)
Silva-Neto, Pedro V. da; Carvalho, Jonatan Constança Silva de; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez ; Silva, Thais Fernanda de Campos Fraga da; Fuzo, Carlos Alessandro; Oliveira, Camilla Narjara Simão; Rodrigues, Lilian Cataldi ; Argolo, Jamille Guedes Malta; Carmona-Garcia, Ingryd; Souza, Camila de Oliveira Silva e ; Fernandes, Talita Morais; Bastos, Victor Alexandre Félix; Parra, Rogério Serafim ; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Frantz, Fabiani Gai ; Gerlach, Raquel Fernanda ; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Fernandes, Ana Paula Morais ; Santos, Isabel Kinney Ferreira de Miranda ; Bonato, Vânia Luiza Deperon ; Baruffi, Marcelo Dias ; Cardoso, Cristina Ribeiro de Barros ; Faccioli, Lucia Helena ; Sorgi, Carlos Arterio ; Xavier, Ana Carolina; Porcel, Giovanna da Silva; Guarneri, Isabelle Cristina; Zaparoli, Kamila; Garbato, Caroline Tempesta; Ferreira Junior, Angelo Alves; Milanezi, Cristiane Maria
Source: Viruses. Unidades: FCFRP, FMRP, FORP, EERP, FFCLRP, EE/EERP
Subjects: COVID-19, BIOMARCADORES, INFLAMAÇÃO, CÉLULAS MIELOIDES, CUIDADOS INTENSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-NETO, Pedro V. da et al. sTREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity. Viruses, v. 13, n. 12, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/v13122521. Acesso em: 07 nov. 2024.
APA
Silva-Neto, P. V. da, Carvalho, J. C. S. de, Pimentel, V. E., Pérez, M. M., Silva, T. F. de C. F. da, Fuzo, C. A., et al. (2021). sTREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity. Viruses, 13( 12), 1-17. doi:10.3390/v13122521
NLM
Silva-Neto PV da, Carvalho JCS de, Pimentel VE, Pérez MM, Silva TF de CF da, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Souza C de OS e, Fernandes TM, Bastos VAF, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Frantz FG, Gerlach RF, Russo EM de S, Viana AL, Fernandes APM, Santos IKF de M, Bonato VLD, Baruffi MD, Cardoso CR de B, Faccioli LH, Sorgi CA, Xavier AC, Porcel G da S, Guarneri IC, Zaparoli K, Garbato CT, Ferreira Junior AA, Milanezi CM. sTREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity [Internet]. Viruses. 2021 ; 13( 12): 1-17.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v13122521
Vancouver
Silva-Neto PV da, Carvalho JCS de, Pimentel VE, Pérez MM, Silva TF de CF da, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Souza C de OS e, Fernandes TM, Bastos VAF, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Frantz FG, Gerlach RF, Russo EM de S, Viana AL, Fernandes APM, Santos IKF de M, Bonato VLD, Baruffi MD, Cardoso CR de B, Faccioli LH, Sorgi CA, Xavier AC, Porcel G da S, Guarneri IC, Zaparoli K, Garbato CT, Ferreira Junior AA, Milanezi CM. sTREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity [Internet]. Viruses. 2021 ; 13( 12): 1-17.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v13122521
Artigo de periodico
COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes (2021)
Fraga-Silva, Thais Fernanda de Campos; Maruyama, Sandra Regina; Sorgi, Carlos Arterio ; Russo, Elisa Maria de Sousa ; Fernandes, Ana Paula Morais ; Cardoso, Cristina Ribeiro de Barros; Faccioli, Lucia Helena ; Dias-Baruffi, Marcelo; Bonato, Vânia Luiza Deperon
Source: Frontiers in Immunology. Unidades: FFCLRP, FCFRP, EERP, FMRP
Subjects: CORONAVIRUS, SISTEMA IMUNE, INFLAMAÇÃO, PULMÃO, IMUNOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGA-SILVA, Thais Fernanda de Campos et al. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.599736. Acesso em: 07 nov. 2024.
APA
Fraga-Silva, T. F. de C., Maruyama, S. R., Sorgi, C. A., Russo, E. M. de S., Fernandes, A. P. M., Cardoso, C. R. de B., et al. (2021). COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.599736
NLM
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2020.599736
Vancouver
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2020.599736
Artigo de periodico
Microbiota modulation of the gut-lung axis in COVID-19 (2021)
Oliveira, Gislane Lelis Vilela de; Oliveira, Camilla Narjara Simão; Pinzan, Camila Figueiredo; Salis, Larissa Vedovato Vilela de; Cardoso, Cristina Ribeiro de Barros
Source: Frontiers in Immunology. Unidades: FCFRP, FMRP
Subjects: COVID-19, INTESTINOS, PULMÃO, PROBIÓTICOS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Gislane Lelis Vilela de et al. Microbiota modulation of the gut-lung axis in COVID-19. Frontiers in Immunology, v. 12, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.635471. Acesso em: 07 nov. 2024.
APA
Oliveira, G. L. V. de, Oliveira, C. N. S., Pinzan, C. F., Salis, L. V. V. de, & Cardoso, C. R. de B. (2021). Microbiota modulation of the gut-lung axis in COVID-19. Frontiers in Immunology, 12, 1-14. doi:10.3389/fimmu.2021.635471
NLM
Oliveira GLV de, Oliveira CNS, Pinzan CF, Salis LVV de, Cardoso CR de B. Microbiota modulation of the gut-lung axis in COVID-19 [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.635471
Vancouver
Oliveira GLV de, Oliveira CNS, Pinzan CF, Salis LVV de, Cardoso CR de B. Microbiota modulation of the gut-lung axis in COVID-19 [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.635471
Artigo de periodico
Toll-like receptor 10 controls TLR2-induced cytokine production in monocytes from patients with Parkinson's disease (2021)
Sobrinho, Hermínio Maurício da Rocha; Gomes, Rodrigo Saar; Silva, Delson José da; Quixabeira, Valéria Bernadete Leite; Joosten, Leo A. B.; Cardoso, Cristina Ribeiro de Barros; Ribeiro-Dias, Fátima
Source: Journal of Neuroscience Research. Unidade: FCFRP
Subjects: CULTURA DE CÉLULAS, CITOTOXINAS, LEUCÓCITOS MONONUCLEARES, MONÓCITOS, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOBRINHO, Hermínio Maurício da Rocha et al. Toll-like receptor 10 controls TLR2-induced cytokine production in monocytes from patients with Parkinson's disease. Journal of Neuroscience Research, v. 99, n. 10, p. 2511-2524, 2021Tradução . . Disponível em: https://doi.org/10.1002/jnr.24916. Acesso em: 07 nov. 2024.
APA
Sobrinho, H. M. da R., Gomes, R. S., Silva, D. J. da, Quixabeira, V. B. L., Joosten, L. A. B., Cardoso, C. R. de B., & Ribeiro-Dias, F. (2021). Toll-like receptor 10 controls TLR2-induced cytokine production in monocytes from patients with Parkinson's disease. Journal of Neuroscience Research, 99( 10), 2511-2524. doi:10.1002/jnr.24916
NLM
Sobrinho HM da R, Gomes RS, Silva DJ da, Quixabeira VBL, Joosten LAB, Cardoso CR de B, Ribeiro-Dias F. Toll-like receptor 10 controls TLR2-induced cytokine production in monocytes from patients with Parkinson's disease [Internet]. Journal of Neuroscience Research. 2021 ; 99( 10): 2511-2524.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/jnr.24916
Vancouver
Sobrinho HM da R, Gomes RS, Silva DJ da, Quixabeira VBL, Joosten LAB, Cardoso CR de B, Ribeiro-Dias F. Toll-like receptor 10 controls TLR2-induced cytokine production in monocytes from patients with Parkinson's disease [Internet]. Journal of Neuroscience Research. 2021 ; 99( 10): 2511-2524.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/jnr.24916
Artigo de periodico
AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis (2021)
Lara, Priscila Guirão; Esteves, Eliane Virgínia da Silva ; Campos, Helioswilton Sales de; Assis, Josiane Betim de ; Henrique, Maressa de Oliveira ; Barros, Michele Silva de; Santos Neto, Leila; Silva Junior, Pedro I. ; Martins, Joilson de Oliveira ; Cardoso, Cristina Ribeiro de Barros; Ribeiro, José M. C.; Nunes, Anderson de Sá
Source: Frontiers in Immunology. Unidades: ICB, FCF, FCFRP
Subjects: IMUNOLOGIA, PEPTÍDEOS, AEDES, GLÂNDULAS SALIVARES, MACRÓFAGOS, COLITE, ADJUVANTES IMUNOLÓGICOS, SALIVA, ÓXIDO NÍTRICO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LARA, Priscila Guirão et al. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis. Frontiers in Immunology, v. 12, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.681671. Acesso em: 07 nov. 2024.
APA
Lara, P. G., Esteves, E. V. da S., Campos, H. S. de, Assis, J. B. de, Henrique, M. de O., Barros, M. S. de, et al. (2021). AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis. Frontiers in Immunology, 12, 1-15. doi:10.3389/fimmu.2021.681671
NLM
Lara PG, Esteves EV da S, Campos HS de, Assis JB de, Henrique M de O, Barros MS de, Santos Neto L, Silva Junior PI, Martins J de O, Cardoso CR de B, Ribeiro JMC, Nunes A de S. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.681671
Vancouver
Lara PG, Esteves EV da S, Campos HS de, Assis JB de, Henrique M de O, Barros MS de, Santos Neto L, Silva Junior PI, Martins J de O, Cardoso CR de B, Ribeiro JMC, Nunes A de S. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.681671
Artigo de periodico-carta/editorial
What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden [Carta] (2021)
Cardoso, Cristina Ribeiro de Barros; Fernandes, Ana Paula Morais ; Santos, Isabel Kinney Ferreira de Miranda
Source: Revista Sociedade Brasileira de Medicina Tropical. Unidades: FCFRP, EERP, FMRP
Subjects: EPIDEMIOLOGIA, COVID-19, COMUNICAÇÃO, PANDEMIAS, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Cristina Ribeiro de Barros e FERNANDES, Ana Paula Morais e SANTOS, Isabel Kinney Ferreira de Miranda. What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden [Carta]. Revista Sociedade Brasileira de Medicina Tropical. Uberaba: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1590/0037-8682-0713-2020. Acesso em: 07 nov. 2024. , 2021
APA
Cardoso, C. R. de B., Fernandes, A. P. M., & Santos, I. K. F. de M. (2021). What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden [Carta]. Revista Sociedade Brasileira de Medicina Tropical. Uberaba: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1590/0037-8682-0713-2020
NLM
Cardoso CR de B, Fernandes APM, Santos IKF de M. What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden [Carta] [Internet]. Revista Sociedade Brasileira de Medicina Tropical. 2021 ; 54 1-2.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/0037-8682-0713-2020
Vancouver
Cardoso CR de B, Fernandes APM, Santos IKF de M. What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden [Carta] [Internet]. Revista Sociedade Brasileira de Medicina Tropical. 2021 ; 54 1-2.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/0037-8682-0713-2020
Artigo de periodico-carta/editorial
Editorial: intestinal dysbiosis in inflammatory diseases [Editorial] (2021)
Oliveira, Gislane Lelis Vilela de; Cardoso, Cristina Ribeiro de Barros; Taneja, Veena; Fasano, Alessio
Source: Frontiers in Immunology. Unidade: FCFRP
Subjects: ENTEROPATIAS INFLAMATÓRIAS, INTESTINOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Gislane Lelis Vilela de et al. Editorial: intestinal dysbiosis in inflammatory diseases [Editorial]. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2021.727485. Acesso em: 07 nov. 2024. , 2021
APA
Oliveira, G. L. V. de, Cardoso, C. R. de B., Taneja, V., & Fasano, A. (2021). Editorial: intestinal dysbiosis in inflammatory diseases [Editorial]. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2021.727485
NLM
Oliveira GLV de, Cardoso CR de B, Taneja V, Fasano A. Editorial: intestinal dysbiosis in inflammatory diseases [Editorial] [Internet]. Frontiers in Immunology. 2021 ; 12 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.727485
Vancouver
Oliveira GLV de, Cardoso CR de B, Taneja V, Fasano A. Editorial: intestinal dysbiosis in inflammatory diseases [Editorial] [Internet]. Frontiers in Immunology. 2021 ; 12 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.727485
Artigo de periodico-carta/editorial
Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. (2021)
Santos, Isabel Kinney Ferreira de Miranda ; Cardoso, Cristina Ribeiro de Barros
Source: Clinical Immunology. Unidades: FMRP, FCFRP
Subjects: COVID-19, ATIVAÇÃO DE COMPLEMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Isabel Kinney Ferreira de Miranda e CARDOSO, Cristina Ribeiro de Barros. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clim.2020.108618. Acesso em: 07 nov. 2024. , 2021
APA
Santos, I. K. F. de M., & Cardoso, C. R. de B. (2021). Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.clim.2020.108618
NLM
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Vancouver
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Artigo de periodico
Peroxisome proliferator-activated receptor alpha mediates the beneficial effects of atorvastatin in experimental colitis (2021)
Basso, Paulo José; Sales-Campos, Helioswilton; Nardini, Viviani ; Duarte-Silva, Murillo ; Alves, Vanessa Beatriz Freitas; Bonfá, Giuliano; Rodrigues, Cassiano Costa; Nunes, Bruno Ghirotto ; Chica, Javier Emílio Lazo; Nomizo, Auro; Cardoso, Cristina Ribeiro de Barros
Source: Frontiers in Immunology. Unidades: FCFRP, ICB, FMRP
Subjects: ENTEROPATIAS INFLAMATÓRIAS, COLITE ULCERATIVA, DOENÇA DE CROHN, INTERLEUCINA 10, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSO, Paulo José et al. Peroxisome proliferator-activated receptor alpha mediates the beneficial effects of atorvastatin in experimental colitis. Frontiers in Immunology, v. 12, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.618365. Acesso em: 07 nov. 2024.
APA
Basso, P. J., Sales-Campos, H., Nardini, V., Duarte-Silva, M., Alves, V. B. F., Bonfá, G., et al. (2021). Peroxisome proliferator-activated receptor alpha mediates the beneficial effects of atorvastatin in experimental colitis. Frontiers in Immunology, 12, 1-14. doi:10.3389/fimmu.2021.618365
NLM
Basso PJ, Sales-Campos H, Nardini V, Duarte-Silva M, Alves VBF, Bonfá G, Rodrigues CC, Nunes BG, Chica JEL, Nomizo A, Cardoso CR de B. Peroxisome proliferator-activated receptor alpha mediates the beneficial effects of atorvastatin in experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.618365
Vancouver
Basso PJ, Sales-Campos H, Nardini V, Duarte-Silva M, Alves VBF, Bonfá G, Rodrigues CC, Nunes BG, Chica JEL, Nomizo A, Cardoso CR de B. Peroxisome proliferator-activated receptor alpha mediates the beneficial effects of atorvastatin in experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.618365
Artigo de periodico
Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy (2021)
Pérez, Malena Martínez ; Pimentel, Vinícius E.; Fuzo, Carlos Alessandro ; Silva-Neto, Pedro V. da; Toro, Diana M.; Souza, Camila O. S.; Fraga-Silva, Thais Fernanda de Campos ; Gardinassi, Luiz Gustavo; Carvalho, Jonatan C. S. de; Neto, Nicola T.; Carmona-Garcia, Ingryd; Oliveira, Camilla N. S.; Milanezi, Cristiane Maria; Takahashi, Viviani Nardini ; Leo, Thais Canassa de ; Rodrigues, Lilian C.; Dias, Cassia F. S. L.; Xavier, Ana Carolina; Porcel, Giovanna da Silva ; Guarneri, Isabelle Cristina; Zaparoli, Kamila; Garbato, Caroline Tempesta; Argolo, Jamille Guedes Malta; Júnior, Angelo Calori; Feitosa, Marley Ribeiro; Parra, Rogério Serafim ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Vilar, Fernando C.; Gaspar, Gilberto Gambero ; Silva, Rafael C. da; Constant, Leticia F.; Ostini, Fátima M.; Amorim, Alessandro P. de; Degiovani, Augusto M.; Silva, Dayane P. da; Nepomuceno, Debora C.; Barbieri, Rita C. C.; Santos, Isabel Kinney Ferreira de Miranda ; Maruyama, Sandra Regina Costa ; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Fernandes, Ana Paula Morais ; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena
Source: MedRXiv. Unidades: FMRP, EERP, FCFRP, FFCLRP, EE/EERP
Subjects: COVID-19, HORMÔNIOS GLICOCORTICOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PÉREZ, Malena Martínez et al. Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy. MedRXiv, p. 1-84, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.01.07.20248970. Acesso em: 07 nov. 2024.
APA
Pérez, M. M., Pimentel, V. E., Fuzo, C. A., Silva-Neto, P. V. da, Toro, D. M., Souza, C. O. S., et al. (2021). Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy. MedRXiv, 1-84. doi:10.1101/2021.01.07.20248970
NLM
Pérez MM, Pimentel VE, Fuzo CA, Silva-Neto PV da, Toro DM, Souza COS, Fraga-Silva TF de C, Gardinassi LG, Carvalho JCS de, Neto NT, Carmona-Garcia I, Oliveira CNS, Milanezi CM, Takahashi VN, Leo TC de, Rodrigues LC, Dias CFSL, Xavier AC, Porcel G da S, Guarneri IC, Zaparoli K, Garbato CT, Argolo JGM, Júnior AC, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Silva RC da, Constant LF, Ostini FM, Amorim AP de, Degiovani AM, Silva DP da, Nepomuceno DC, Barbieri RCC, Santos IKF de M, Maruyama SRC, Russo EM de S, Viana AL, Fernandes APM, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH. Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy [Internet]. MedRXiv. 2021 ; 1-84.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2021.01.07.20248970
Vancouver
Pérez MM, Pimentel VE, Fuzo CA, Silva-Neto PV da, Toro DM, Souza COS, Fraga-Silva TF de C, Gardinassi LG, Carvalho JCS de, Neto NT, Carmona-Garcia I, Oliveira CNS, Milanezi CM, Takahashi VN, Leo TC de, Rodrigues LC, Dias CFSL, Xavier AC, Porcel G da S, Guarneri IC, Zaparoli K, Garbato CT, Argolo JGM, Júnior AC, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Silva RC da, Constant LF, Ostini FM, Amorim AP de, Degiovani AM, Silva DP da, Nepomuceno DC, Barbieri RCC, Santos IKF de M, Maruyama SRC, Russo EM de S, Viana AL, Fernandes APM, Bonato VLD, Cardoso CR de B, Sorgi CA, Dias-Baruffi M, Faccioli LH. Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy [Internet]. MedRXiv. 2021 ; 1-84.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2021.01.07.20248970
Artigo de periodico
The influence of dehydroepiandrosterone on effector functions of neutrophils (2021)
Brauer, Verônica Soares; Zambuzi, Fabiana Albani; Espíndola, Milena Sobral; Cavalcanti Neto, Marinaldo Pacífico; Prado, Morgana Kelly Borges; Silva, Priscilla Mariane Cardoso; Soares, Luana Silva; Lima, Leonardo Judson Galvão de; Leopoldino, Andréia Machado ; Cardoso, Cristina Ribeiro de Barros; Frantz, Fabiani Gai
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: FAGOCITOSE, NEUTRÓFILOS, HORMÔNIOS SEXUAIS, SALMONELLA TYPHIMURIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAUER, Verônica Soares et al. The influence of dehydroepiandrosterone on effector functions of neutrophils. Brazilian Journal of Pharmaceutical Sciences, v. 57, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902020000419139. Acesso em: 07 nov. 2024.
APA
Brauer, V. S., Zambuzi, F. A., Espíndola, M. S., Cavalcanti Neto, M. P., Prado, M. K. B., Silva, P. M. C., et al. (2021). The influence of dehydroepiandrosterone on effector functions of neutrophils. Brazilian Journal of Pharmaceutical Sciences, 57, 1-15. doi:10.1590/s2175-97902020000419139
NLM
Brauer VS, Zambuzi FA, Espíndola MS, Cavalcanti Neto MP, Prado MKB, Silva PMC, Soares LS, Lima LJG de, Leopoldino AM, Cardoso CR de B, Frantz FG. The influence of dehydroepiandrosterone on effector functions of neutrophils [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2021 ; 57 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/s2175-97902020000419139
Vancouver
Brauer VS, Zambuzi FA, Espíndola MS, Cavalcanti Neto MP, Prado MKB, Silva PMC, Soares LS, Lima LJG de, Leopoldino AM, Cardoso CR de B, Frantz FG. The influence of dehydroepiandrosterone on effector functions of neutrophils [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2021 ; 57 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/s2175-97902020000419139
Artigo de periodico
The aryl hydrocarbon receptor (ahr) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor (2020)
Pernomian, Larissa; Duarte-Silva, Murillo ; Cardoso, Cristina Ribeiro de Barros
Source: Clinical Reviews in Allergy & Immunology. Unidades: FCFRP, FMRP
Subjects: INFLAMAÇÃO, ENTEROPATIAS INFLAMATÓRIAS, HIDROCARBONETOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERNOMIAN, Larissa e DUARTE-SILVA, Murillo e CARDOSO, Cristina Ribeiro de Barros. The aryl hydrocarbon receptor (ahr) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor. Clinical Reviews in Allergy & Immunology, v. 59, n. 3, p. 382-390, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12016-020-08789-3. Acesso em: 07 nov. 2024.
APA
Pernomian, L., Duarte-Silva, M., & Cardoso, C. R. de B. (2020). The aryl hydrocarbon receptor (ahr) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor. Clinical Reviews in Allergy & Immunology, 59( 3), 382-390. doi:10.1007/s12016-020-08789-3
NLM
Pernomian L, Duarte-Silva M, Cardoso CR de B. The aryl hydrocarbon receptor (ahr) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor [Internet]. Clinical Reviews in Allergy & Immunology. 2020 ; 59( 3): 382-390.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s12016-020-08789-3
Vancouver
Pernomian L, Duarte-Silva M, Cardoso CR de B. The aryl hydrocarbon receptor (ahr) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor [Internet]. Clinical Reviews in Allergy & Immunology. 2020 ; 59( 3): 382-390.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s12016-020-08789-3
Artigo de periodico
The signal transducer and activator of transcription 6 (STAT-6) mediates Th2 inflammation and tissue damage in a murine model of peanut-induced food allergy (2019)
Cardoso, Cristina Ribeiro de Barros ; Provinciatto, Pauline Rossetti; Godoi, Dannielle Fernandes; Fonseca, Monique Thaís Costa ; Ferreira, Beatriz Rossetti ; Teixeira, Gerlinde Agate Platais Brasil ; Cunha, Fernando de Queiroz ; Pinzan, Camila Figueiredo; Silva, João Santana da
Source: Allergologia et Immunopathologia. Unidades: FCFRP, EERP, FMRP
Subjects: HIPERSENSIBILIDADE ALIMENTAR, INFLAMAÇÃO, INTESTINOS, GASTROENTEROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Cristina Ribeiro de Barros et al. The signal transducer and activator of transcription 6 (STAT-6) mediates Th2 inflammation and tissue damage in a murine model of peanut-induced food allergy. Allergologia et Immunopathologia, v. 47, n. 6, p. 535-543, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.aller.2019.02.006. Acesso em: 07 nov. 2024.
APA
Cardoso, C. R. de B., Provinciatto, P. R., Godoi, D. F., Fonseca, M. T. C., Ferreira, B. R., Teixeira, G. A. P. B., et al. (2019). The signal transducer and activator of transcription 6 (STAT-6) mediates Th2 inflammation and tissue damage in a murine model of peanut-induced food allergy. Allergologia et Immunopathologia, 47( 6), 535-543. doi:10.1016/j.aller.2019.02.006
NLM
Cardoso CR de B, Provinciatto PR, Godoi DF, Fonseca MTC, Ferreira BR, Teixeira GAPB, Cunha F de Q, Pinzan CF, Silva JS da. The signal transducer and activator of transcription 6 (STAT-6) mediates Th2 inflammation and tissue damage in a murine model of peanut-induced food allergy [Internet]. Allergologia et Immunopathologia. 2019 ; 47( 6): 535-543.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.aller.2019.02.006
Vancouver
Cardoso CR de B, Provinciatto PR, Godoi DF, Fonseca MTC, Ferreira BR, Teixeira GAPB, Cunha F de Q, Pinzan CF, Silva JS da. The signal transducer and activator of transcription 6 (STAT-6) mediates Th2 inflammation and tissue damage in a murine model of peanut-induced food allergy [Internet]. Allergologia et Immunopathologia. 2019 ; 47( 6): 535-543.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.aller.2019.02.006
Artigo de periodico
Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease (2019)
Duarte-Silva, Murillo ; Afonso, Poliana Cristina; Souza, Patrícia Reis de; Peghini, Bethânea Crema; Rodrigues Júnior, Virmondes; Cardoso, Cristina Ribeiro de Barros
Source: Autoimmunity. Unidades: FCFRP, FMRP
Subjects: ENTEROPATIAS INFLAMATÓRIAS, DOENÇA DE CROHN, CITOTOXINAS, IMUNOGLOBULINAS, SACCHAROMYCES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE-SILVA, Murillo et al. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Autoimmunity, v. 52, n. 1, p. 37-47, 2019Tradução . . Disponível em: https://doi.org/10.1080/08916934.2019.1588889. Acesso em: 07 nov. 2024.
APA
Duarte-Silva, M., Afonso, P. C., Souza, P. R. de, Peghini, B. C., Rodrigues Júnior, V., & Cardoso, C. R. de B. (2019). Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Autoimmunity, 52( 1), 37-47. doi:10.1080/08916934.2019.1588889
NLM
Duarte-Silva M, Afonso PC, Souza PR de, Peghini BC, Rodrigues Júnior V, Cardoso CR de B. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease [Internet]. Autoimmunity. 2019 ; 52( 1): 37-47.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/08916934.2019.1588889
Vancouver
Duarte-Silva M, Afonso PC, Souza PR de, Peghini BC, Rodrigues Júnior V, Cardoso CR de B. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease [Internet]. Autoimmunity. 2019 ; 52( 1): 37-47.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/08916934.2019.1588889
Artigo de periodico
Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis (2018)
Souza, Patrícia Reis de; Guimarães, Francielle Rodrigues; Sales-Campos, Helioswilton; Bonfá, Giuliano; Nardini, Viviani; Chica, Javier Emilio Lazo; Turato, Walter Miguel; Silva, João Santana da; Zamboni, Dario Simões; Cardoso, Cristina Ribeiro de Barros
Source: Immunobiology. Unidades: FCF, FMRP, FCFRP
Subjects: IMUNIDADE, ENTEROPATIAS INFLAMATÓRIAS, LINFÓCITOS T, CITOCININAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Patrícia Reis de et al. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis. Immunobiology, v. 223, n. 10, p. 577-585, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.imbio.2018.07.003. Acesso em: 07 nov. 2024.
APA
Souza, P. R. de, Guimarães, F. R., Sales-Campos, H., Bonfá, G., Nardini, V., Chica, J. E. L., et al. (2018). Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis. Immunobiology, 223( 10), 577-585. doi:10.1016/j.imbio.2018.07.003
NLM
Souza PR de, Guimarães FR, Sales-Campos H, Bonfá G, Nardini V, Chica JEL, Turato WM, Silva JS da, Zamboni DS, Cardoso CR de B. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis [Internet]. Immunobiology. 2018 ; 223( 10): 577-585.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.imbio.2018.07.003
Vancouver
Souza PR de, Guimarães FR, Sales-Campos H, Bonfá G, Nardini V, Chica JEL, Turato WM, Silva JS da, Zamboni DS, Cardoso CR de B. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis [Internet]. Immunobiology. 2018 ; 223( 10): 577-585.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.imbio.2018.07.003

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation